Checkpoint Therapeutics, Inc. (CKPT) Financials

CKPT Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 2.2 million 21.3 million
2023-06-30 8.3 million 31.6 million
2023-03-31 5.9 million 28.1 million
2022-12-31 13.3 million 32.8 million

CKPT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -14.8 million 689000
2023-06-30 -12.0 million 567000
2023-03-31 -14.0 million 969000
2022-12-31 -15.3 million 639000

CKPT Net Income

No data available :(

CKPT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 1.8 million - -
2023-06-30 7.4 million - -
2023-03-31 4.8 million - -
2022-12-31 12.1 million - -

CKPT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 20.0 million
2023-06-30 15.7 million
2023-03-31 11.7 million
2022-12-31 8.8 million

CKPT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 5.5 million 2.2 million -
2023-06-30 - 13.9 million 2.3 million -
2023-03-31 - 15.8 million 2.3 million -
2022-12-31 - 14.2 million 2.5 million -

CKPT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 31000 -
2023-06-30 31000 13.9 million
2023-03-31 35000 15.8 million
2022-12-31 74000 14.2 million

CKPT

Price: $1.48

52 week price:
1.30
3.62

Earnings Per Share: -3.17 USD

P/E Ratio: -0.46

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 87100

Ebitda: -5.9 million

Market Capitalization: 65.3 million

Links: